Psychiatric Medication Is in Dire Need of Innovation

Psychiatric medication is in dire need of innovation

There can be no either/or in mental health — we must rigorously examine pharmaceutical and social solutions

#Progress in Novel Pharmacotherapies for Mood and Anxiety Disorders Leveraging Lipid Signaling Pathways

The treatment of mood and anxiety disorders continues to present significant challenges, prompting ongoing research into novel therapeutic pathways. Traditional pharmacologic approaches, primarily selective serotonin reuptake inhibitors (SSRIs), have finite efficacy and are often accompanied by adverse effects that can compromise patient adherence. Recent advancements in lipid signaling pathway modulation, particularly through the development of…